AU9247698A - Method for the identification of essential genes and therapeutic targets - Google Patents

Method for the identification of essential genes and therapeutic targets

Info

Publication number
AU9247698A
AU9247698A AU92476/98A AU9247698A AU9247698A AU 9247698 A AU9247698 A AU 9247698A AU 92476/98 A AU92476/98 A AU 92476/98A AU 9247698 A AU9247698 A AU 9247698A AU 9247698 A AU9247698 A AU 9247698A
Authority
AU
Australia
Prior art keywords
identification
therapeutic targets
essential genes
genes
essential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU92476/98A
Inventor
Guy Cardinal
Roger C. Levesque
Francois Sanschagrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Laval filed Critical Universite Laval
Publication of AU9247698A publication Critical patent/AU9247698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU92476/98A 1997-09-19 1998-09-21 Method for the identification of essential genes and therapeutic targets Abandoned AU9247698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2215870 1997-09-19
CA 2215870 CA2215870A1 (en) 1997-09-19 1997-09-19 Method for the identification of essential genes and therapeutic targets
PCT/CA1998/000893 WO1999015644A2 (en) 1997-09-19 1998-09-21 Method for the identification of essential genes and therapeutic targets

Publications (1)

Publication Number Publication Date
AU9247698A true AU9247698A (en) 1999-04-12

Family

ID=4161494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92476/98A Abandoned AU9247698A (en) 1997-09-19 1998-09-21 Method for the identification of essential genes and therapeutic targets

Country Status (3)

Country Link
AU (1) AU9247698A (en)
CA (1) CA2215870A1 (en)
WO (1) WO1999015644A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058457A2 (en) * 1999-03-31 2000-10-05 Rosetta Inpharmatics, Inc. Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
GB0008748D0 (en) * 2000-04-11 2000-05-31 Univ Manchester Mutant bank
CN1329034A (en) * 2000-06-19 2002-01-02 上海博德基因开发有限公司 A novel polypeptide-human L1 components ORF2 protein 21 and polynucleotide for coding this polypeptide
WO2002083940A2 (en) * 2001-04-06 2002-10-24 Creatogen Aktiengesellschaft Screening method for anti-microbial drug targets by genome-saturing mutagenesis (gsm)
GB0321232D0 (en) * 2003-09-10 2003-10-08 Arrow Therapeutics Ltd Method for the identification of attenuating lesions in pathogens
EP3170902A1 (en) 2015-11-19 2017-05-24 ETH Zurich Parallel functional testing of synthetic dna parts, pathways, and genomes
CN105400876B (en) * 2015-12-03 2019-06-11 天津科技大学 Pseudomonas aeruginosa and phage-infect related gene and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026933A1 (en) * 1993-05-13 1994-11-24 The Board Of Trustees Of The Leland Stanford Junior University Genetic footprinting: insertional mutagenesis and genetic selection

Also Published As

Publication number Publication date
CA2215870A1 (en) 1999-03-19
WO1999015644A3 (en) 1999-05-20
WO1999015644A2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU6564398A (en) Wagering system and method of wagering
AU4787697A (en) Therapeutic gene
AU5683196A (en) N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs
AU8830998A (en) Player tracking and identification system
AU9035898A (en) Electrosurgical systems and methods for the removal of pacemaker leads
AU9028798A (en) Method of improving drug treatment
AUPN698495A0 (en) Improved therapeutic formulation and method
AU5268696A (en) Novel compounds and methods for therapy
AU6535096A (en) Methods and means for targeted gene delivery
AU7250098A (en) Anastomosis system and method of use
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
AU5961598A (en) Pari-mutuel gaming system and method of using same
AU7125198A (en) Defibrillator method and apparatus
AU3560399A (en) Tumor associated nucleic acids and uses therefor
AUPN741696A0 (en) Delivery of nucleic acids ii
AU2930697A (en) Identification of essential survival genes
AU7277598A (en) Energy delivery of catheter and method for the use thereof
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU2051297A (en) Gene therapy method using fgf-5
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU4397797A (en) Method of gene introduction
AU9247698A (en) Method for the identification of essential genes and therapeutic targets
AU6646798A (en) Method and apparatus for the destruction of articles
AU8816898A (en) Method of drug selection
AU7015300A (en) Method and system of purchase and payment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase